SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-156249
Filing Date
2021-05-10
Accepted
2021-05-10 16:15:03
Documents
3
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d787368d8k.htm 8-K 18809
2 EX-99.1 d787368dex991.htm EX-99.1 50690
3 GRAPHIC g787368dsp5.jpg GRAPHIC 5045
  Complete submission text file 0001193125-21-156249.txt   77890
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 21907381
SIC: 2834 Pharmaceutical Preparations